Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing a recent study examining the safety and efficacy of Ofev in patients with poor lung function. While the researchers recommended additional studies to understand more, the results demonstrated that Ofev is effective and safe in patients with poor lung function, defined as equal to or less than 50% forced vital capacity (FVC).

Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com